Alyeska Investment Group, L.P. - 31 Mar 2025 SCHEDULE 13G/A Report for Unity Biotechnology, Inc. Common Stock, par value $0.0001 (UBX)

Filing Manager
Alyeska Investment Group, L.P.
Reporting Manager
Alyeska Investment Group, L.P.
Security
Unity Biotechnology, Inc. Common Stock, par value $0.0001
Symbol
UBX
Shares outstanding
17,209,280 shares
Disclosed Ownership
1,578,091 shares
Ownership
9.2%
Form type
SCHEDULE 13G/A
Filing time
15 May 2025, 16:31:19 UTC
Date of event
31 Mar 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Alyeska Investment Group, L.P. 9.2% 1,578,091 0 1,578,091 Jason Bragg Jason Bragg | Chief Financial Officer
Alyeska Fund GP, LLC 9.2% 1,578,091 0 1,578,091 Jason Bragg Jason Bragg | Chief Financial Officer
Anand Parekh 9.2% 1,578,091 0 1,578,091 Anand Parekh Anand Parekh | Self